Abivax S.A.
AAVXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$176,242 | -$147,740 | -$69,846 | -$41,357 |
| Dep. & Amort. | $1,100 | $707 | $71 | $156 |
| Deferred Tax | $0 | $0 | $1,022 | -$1,141 |
| Stock-Based Comp. | $20,224 | $8,179 | -$1,164 | $828 |
| Change in WC | $1,423 | $21,265 | -$10,089 | -$1,414 |
| Other Non-Cash | -$577 | $20,459 | $14,427 | -$2,730 |
| Operating Cash Flow | -$154,072 | -$97,130 | -$65,579 | -$45,657 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$640 | -$265 | -$3,968 | -$1,642 |
| Net Acquisitions | $0 | $0 | $14 | $312 |
| Inv. Purchases | $0 | -$9,351 | -$142 | -$9 |
| Inv. Sales/Matur. | $0 | $741 | $390 | $9 |
| Other Inv. Act. | $16,402 | $780 | -$21 | -$126 |
| Investing Cash Flow | $15,762 | -$8,095 | -$3,727 | -$1,456 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $37,486 | $15,239 | -$9,711 | $19,127 |
| Stock Issued | $434 | $353,387 | $46,374 | $69,683 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$9,713 | -$33,336 | -$4,452 | -$6,131 |
| Financing Cash Flow | $28,207 | $335,290 | $35,556 | $78,512 |
| Forex Effect | $2,382 | -$5,072 | -$1 | $0 |
| Net Chg. in Cash | -$107,721 | $224,992 | -$33,751 | $31,399 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $251,942 | $26,950 | $60,695 | $29,296 |
| End Cash | $144,221 | $251,942 | $26,944 | $60,695 |
| Free Cash Flow | -$154,715 | -$97,395 | -$69,547 | -$47,299 |